Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Cost of product revenues: 94.96M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Cost of product revenues: 94.96M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.23, $0.22 better than the analyst estimate of $0.01. Revenue for the quarter came in at $294.4 million versus the consensus estimate of $299.6 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- OSI Systems (OSIS) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
